Clinical inertia in patients with T2DM requiring insulin in family practice

Canadian Family Physician

Volumn 56, Issue 12, 2010, Pages

  Harris, Stewart B ^a,b   Kapor, Jovana ^c   Lank, Cynthia N ^b   Willan, Andrew R ^d,e   Houston, Tricia ^c  

^a WESTERN UNIVERSITY   (Canada)

^b Department of Diabetes Management ^*

^c NOVO NORDISK A S   (Denmark)

^d HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN; INSULIN; MEGLITINIDE; METFORMIN; SULFONYLUREA; TETRAHYDROLIPSTATIN;

ARTICLE; CANADA; DRUG EFFICACY; DRUG USE; FOLLOW UP; GENERAL PRACTICE; GLYCEMIC CONTROL; HEALTH STATUS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY MEDICAL CARE; QUESTIONNAIRE;

EID: 78650430047     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Jaakkimainen L, Biaju RS, Kopp A. Sources of physician care for people with diabetes. In: Hux J, Booth G, Slaughter P, Slaughter P, Laupacis A, editors. Diabetes in Ontario: an ICES practice atlas. Toronto, ON: Institute for Clinical Evaluative Sciences; 2003. p. 9.181-92. Available from: www.ices.on.ca/file/DM-Chapter9. pdf. Accessed 2010 Oct 26.
2. Harris SB, Stewart M, Brown JB, Wetmore S, Faulds C, Webster-Bogaert S, et al. Type 2 diabetes in family practice. Room for improvement. Can Fam Physician 2003;49:778-85.
3. Harris SB, Ekoé JM, Zdanowicz Y, Webster-Bogaert S. Glycemic control and morbidity in the Canadian primary care setting (results of the Diabetes in Canada Evaluation study). Diabetes Res Clin Pract 2005;70(1):90-7.
4. Harris SB, Worrall G, Macaulay A, Norton P, Webster-Bogaert S, Donner A, et al. Diabetes management in Canada: baseline results of the Group Practice Diabetes Management Study. Can J Diabetes 2006;30(2):131-7. Available from: www.diabetes. ca/files/CJDJune06--S.%20Harris.pdf. Accessed 2010 Oct 26.
5. Braga M, Casanova A, Teoh H, Dawson KG, Gerstein HC, Fitchett DH, et al. Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada. Can J Cardiol 2010;26(6):297-302.
6. Spann SJ, Nutting PA, Galliher JM, Peterson KA, Pavlik VN, Dickinson LM, et al. Management of type 2 diabetes in the primary care setting: a practice-based research network study. Ann Fam Med 2006;4(1):23-31.
7. Fox KM, Gerber RA, Bolinder B, Chen J, Kumar S. Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: a series of retrospective analyses of data from 1998 through 2002. Clin Ther 2006;28(3):388-95.
8. Hoerger TJ, Segel JE, Gregg EW, Saaddine JB. Is glycemic control improving in U.S. adults? Diabetes Care 2008;31(1):81-6. Epub 2007 Oct 12.
9. Saaddine JB, Cadwell B, Gregg EW, Engelgua MM, Vinicor F, Imperatore G, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Arch Intern Med 2006;144(7):465-74.
10. Beaton SJ, Nag SS, Gunter MJ, Gleeson JM, Sajjan SS, Alexander CM. Adequacy of glycemic, lipid and blood pressure management for patients with diabetes in a managed care setting. Diabetes Care 2004;27(3):694-8.
11. Ziemer DC, Doyle JP, Barnes CS, Branch WT Jr, Cook CB, El-Kebbi IM, et al. An intervention to overcome clinical inertia and improve diabetes mellitus control in a primary care setting: Improving Primary Care of African Americans with Diabetes (IPCAAD) 8. Arch Intern Med 2006;166(5):507-13.
12. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical inertia. Ann Intern Med 2001;135(9):825-34.
13. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352(9131):837-53.
14. Turner RC, Cull CA, Frighi V, Holman RR; UK Prospective Study (UKPDS) Group. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes. Progressive requirement for multiple therapies (UKPDS 49). JAMA 1999;281(21):2005-12.
15. LeRoith D, Levetan CS, Hirsch IB, Riddle MC. Type 2 diabetes: the role of basal insulin therapy. J Fam Pract 2004;53(3):215-22.
16. Riddle MC. Timely addition of insulin to oral therapy for type 2 diabetes. Diabetes Care 2002;25(2):395-6.
17. Riddle MC. The underuse of insulin therapy in North America. Diabetes Metab Res Rev 2002;18(Suppl 3):S42-9.
18. Canadian Diabetes Association Clinical Practice Guideline Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2003;27(Suppl 2):S1-152.
19. American Diabetes Association. American Diabetes Association 2007 clinical practice recommendations. Diabetes Care 2007;30(Suppl 1):S1-130.
20. IDF Clinical Guidelines Task Force. Global guidelines for type 2 diabetes. Brussels, Belgium: International Diabetes Federation; 2005. Available from: www.idf.org/Global-guideline. Accessed 2010 Oct 26.
21. Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 2004;27(1):17-20.
22. Simons WR, Vinod HD, Gerber RA, Bolinder B. Does rapid transition to insulin therapy in subjects with newly diagnosed type 2 diabetes mellitus benefit glycemic control and diabetes-related complications? A German population-based study. Exp Clin Endocrinol Diabetes 2006;114(9):520-6.
23. Harris SB, Leiter LA, Webster-Bogaert S, Van DM, O'Neill C. Teleconferenced educational detailing: diabetes education for primary care. J Contin Educ Health Prof 2005;25(2):87-97.
24. Hayward RA, Manning WG, Kaplan SH, Wagner EH, Greenfield S. Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization. JAMA 1997;278(20):1663-9.
25. Alvarez Guisasola F, Mavros P, Nocea G, Alemao E, Alexander CM, Yin D. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study. Diabetes Obes Metab 2008;10(Suppl 1):8-15.
26. Gough S, Frandsen KB, Toft AD. Glycaemic control and cardiovascular risk in insulin-treated patients with type 2 diabetes in Germany and the UK [abstract]. Presented at the 44th Annual Meeting of the European Association for the Study of Diabetes; 2008 Sep 2-11; Rome, Italy.
27. Jeavons D, Hungin AP, Cornford CS. Patients with poorly controlled diabetes in primary care: healthcare clinicians' beliefs and attitudes. Postgrad Med J 2006;82(967):347-50.
28. Wallace TM, Matthews DR. Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitudes. QJM 2000;93(6):369-74.
29. Leslie CA, Satin-Rapaport W, Matheson RN, Stone R, Enfield RD. Psychological insulin resistance: a missed diagnosis? Diabetes Spectrum 1994;7(1):52-7.
30. Koytkowski M. When oral agents fail: practical barriers to starting insulin. Int J Obes 2002;26(Suppl 3):S18-24. Available from: www.nature.com/ijo/journal/v26/ n3s/pdf/0802173a.pdf. Accessed 2010 Oct 26.
31. Davis SN, Renda SM. Psychological insulin resistance: overcoming barriers to starting insulin therapy. Diabetes Educ 2006;32(Suppl 4):146S-52S.
32. Parnes BL, Main DS, Dickinson LM, Niebauer L, Holcomb S, Westfall JM, et al. Clinical decisions regarding HbA1c results in primary care: a report from CaReNet and HPRN. Diabetes Care 2004;27(1):13-6.
33. Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005;28(11):2673-9.
34. De Fine Olivarius N, Richelsen B, Siersma V, Andreasen AH, Beck-Nielsen H. Weight history of patients with newly diagnosed type 2 diabetes. Diabet Med 2008;25(8):933-41.
35. Larger E, Rufat P, Dubois-Laforgue D, Ledoux S. Insulin and weight gain: myth or reality? [article in French]. Diabetes Metab 2001;27(5 Pt 3):S23-7.
36. Yki-Järvinen H. Combination therapies with insulin in type 2 diabetes. Diabetes Care 2001;24(4):758-67.
37. College of Family Physicians of Canada, Canadian Medical Association, Royal College of Physicians and Surgeons of Canada. 2007 National Physician Survey. Mississauga, ON: College of Family Physicians of Canada; 2007. Available from: www.nationalphysiciansurvey.ca/nps/2007-Survey/2007nps-e.asp. Accessed 2010 Oct 26.